FDA recall record

Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle recall — FDA D-0012-2025

Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.

Class Iclassification
D-0012-2025official record ID
Oct 23, 2024report date

Recall record at a glance

Official recordD-0012-2025
CategoryDrug Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmBionpharma Inc.
Report dateOct 23, 2024
Recall initiation dateSep 17, 2024
Quantity1,980 bottles
LocationPrinceton, NJ, United States

Official product description

Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.

Why the product was recalled

Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.

Distribution information

Nationwide in the U.S.A.

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Press Release.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.